Nasopharyngeal cancer stage III is usually a malignant tumor with locally advanced condition which is hard to be cured, however, its five-year survival rate is around 45-50%, and the specific survival period is related to the patient’s physique, condition, pathology type, treatment method and many other factors. The treatments for stage III nasopharyngeal cancer mainly include concurrent radiotherapy, chemotherapy plus adjuvant chemotherapy treatment, and the specific chemotherapy program depends on the actual situation of patients. NPC stage III uses chemotherapy along with radiotherapy, its main goal is to improve local control rate and reduce the occurrence of distant metastasis, which improves the survival rate than radiotherapy alone. The five-year survival rate of nasopharyngeal cancer can be more than 90% for early-stage patients after radiotherapy and other treatments; while the five-year survival rate of stage III nasopharyngeal cancer, which is usually in the locally advanced stage, is around 45-50%, and its prognosis is related to the patient’s age, physical fitness, malignancy degree of the tumor as well as whether it recurs or not after the treatment. In addition, whether it is sensitive after the first radiotherapy or chemotherapy treatment affects the survival period. If you are suffering from nasopharyngeal cancer, please consult the hospital in time for early detection and treatment in order to prolong your life.